Skip to content

Effect of acupuncture on patients with cancer-related fatigue during chemotherapy

Acupuncture for prevention and treatment of cancer-related fatigue during chemotherapy: a study protocol for a multicenter, randomized, controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10119971
Enrollment
112
Registered
2015-03-24
Start date
2014-01-01
Completion date
Unknown
Last updated
2015-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer-related fatigue Signs and Symptoms Malaise and fatigue

Interventions

The 112 eligible participants are randomly allocated to two different groups: 1. Participants in the intervention group will receive acupuncture therapy three times a week for 3 weeks. 2. Participants

Sponsors

Beijing Municipal Administration of Hospitals
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with a definite pathologic diagnosis of breast cancer or lung cancer who had completed chemotherapy and/or radiotherapy at least 3 months, or never received chemotherapy and/or radiotherapy ever before 2. Aged 18-75 3. There are at least two cycles of chemotherapy planned during the study program 4. Eastern Cooperative Oncology Group (ECOG) performance status 0-2 5. Traditional Chinese Medicine (TCM) syndrome is differentiated as deficiency of spleen qi and stomach qi 6. Anticipated survival time is more than 6 months 7. All patients provided written informed consent before enrollment

Exclusion criteria

Exclusion criteria: 1. Complicated with other serious heart, liver, kidney, immune and hematopoietic system diseases 2. Pregnant women or women who are breastfeeding 3. Patients who were on active treatment for anaemia (i.e., EPO or blood transfusions) 4. Patients who were receiving steroids to alleviate fatigue 5. Patients who had been diagnosed with depression, anxiety disorders, mental illness and cognitive disorders 6. Patients who had low platelet count or suffered from a bleeding disorder (e.g., haemophilia) 7. Complicated with sepsis or bacteremia 8. Patients who had lymphoedema at the area of the acupuncture points 9. Patients who are allergic to stainless steel needle or had needle phobia

Design outcomes

Primary

MeasureTime frame
Piper Fatigue Scale-Chinese Version (PFS-CV), a multidimensional assessment tool for measuring the level of fatigue subjectively for patients with cancer. It will be assessed before chemotherapy, at the 3rd day, 7th day, 14th day and 21st day during the chemotherapy

Secondary

MeasureTime frame
1. TCM symptoms scale to evaluate TCM syndrome (deficiency of spleen qi and stomach qi) 2. TCM (traditional Chinese medicine) syndrome will be assessed before chemotherapy and at the 3rd day, 7th day, 14th day and 21st day during the chemotherapy

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026